圣诺生物2025年第三季度净利润同比增长8.23%

Core Viewpoint - Shengnuo Bio reported significant growth in both revenue and net profit for the third quarter and the first three quarters of 2025, indicating strong operational performance and market demand [1] Financial Performance - In Q3 2025, the company achieved revenue of 183 million yuan, representing a year-on-year increase of 31.43% [1] - The net profit attributable to shareholders for Q3 2025 was 38.05 million yuan, reflecting a year-on-year growth of 8.23% [1] - For the first three quarters of 2025, the company recorded revenue of 520 million yuan, which is a year-on-year increase of 53.96% [1] - The net profit attributable to shareholders for the first three quarters of 2025 reached 127 million yuan, marking a substantial year-on-year growth of 123.03% [1]